Spring Biotechnology Internship 2027

Cresilon® is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company’s proprietary hydrogel technology. The company’s plant-based technology has revolutionized the current standard by stopping traumatic and surgical bleeds in seconds without the need for extended manual pressure. The company's current and future product lines target veterinary, human trauma, and human surgical applications. Cresilon's mission is to save lives. Learn more about the company at www.cresilon.com.

This Spring, Cresilon is looking to bring on interns from diverse fields in order for them to gain exposure into the industry.

There will be technical and non-technical internships available, which will focus on a specific project. Candidates will be exposed to all aspects of the industry regardless of their placement. The internship is a 15-week onsite program beginning on January 18, 2027 - April 30, 2027. Compensation will be fixed at $30.00/hour for 40 hours/week. Part time opportunities are also available. The application period closes on November 13, 2026.

There are eight internship categories available. Please indicate your Top 2 choices in your attached cover letter:</